Powder: -20°C for 3 years
In solvent: -80°C for 2 years
(S)-Terazosin is an active S-enantiomer of Terazosin. (S)-Terazosin is a potent and high-affinity antagonist of α-adrenoceptor(α1a, α1b and α1d-adrenoceptor with Ki values of 3.91 nM, 0.79 nM and 1.16 nM, respectively).
Description | (S)-Terazosin is an active S-enantiomer of Terazosin. (S)-Terazosin is a potent and high-affinity antagonist of α-adrenoceptor(α1a, α1b and α1d-adrenoceptor with Ki values of 3.91 nM, 0.79 nM and 1.16 nM, respectively). |
Targets&IC50 | α1a-adrenoceptor:ki: 3.91 nM , α2a-adrenoceptor: 729 nM (ki), α1b-adrenoceptor:0.79 nM (ki), α2Ba-adrenoceptor:3.5 nM (ki), α1D-adrenoceptor:1.16 nM (ki), α2C-adrenoceptor:46.4 nM (ki) |
In vitro | (S)-Terazosin and its enantiomers show high and apparently equal affinity for subtypes of α1-adrenoceptors, and showed potent α1-adrenoceptors antagonist in isolated tissues, with the enantiomers approximately equipotent to the racemate at each α1-adrenoceptor subtype. At α2b sites, (R)-Terazosin binds less potently than either the (S)-Terazosin or racemate. |
In vivo | (S)-Terazosin shows α2B receptor antagonist at rat atrial(pEC30 of 6.93). (s)-Terazosin shows antagonism of at rat vas deferens α1A and α2A receptor with pA2 values of 8.3 and 6.12, respectively. |
Molecular Weight | 387.43 |
Formula | C19H25N5O4 |
CAS No. | 109351-33-9 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 150 mg/mL (387.17 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(S)-Terazosin 109351-33-9 GPCR/G Protein Neuroscience Adrenergic Receptor (S) Terazosin (S)Terazosin Inhibitor inhibitor inhibit